SMYD2 and cancer: SMYD2 protein levels are elevated in various cancer types, and overexpression of SMYD2 in cancer cell lines promotes phenotypes associated with oncogenic transformation (Komatsu et al. 2009, 2015; Hamamoto et al. 2014; Sakamoto et al. 2014; Liu et al. 2015).